Elan "buy"

12/28/05 - Goodbody Stockbrokers

LONDON, December 28 (newratings.com) - Analyst Ian Hunter of Goodbody Stockbrokers maintains his "buy" rating on Elan Corp Plc (ECN-EUR).

In a research note published this morning, the analyst mentions that the decision on the return of Tysabri to the US market is expected during late March 2006, since the drug is on priority status for further review. Goodbody Stockbrokers believes that Elan's stock would witness marginal weakness through January, after the company's share price rose 38% during early December.